The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Reelin Depletion is an Early Phenomenon of Alzheimer's Pathology
Abstract
Alterations in the expression of Reelin (RELN) have been implicated in the pathology of Alzheimer's disease (AD). However, whether these changes are cause or consequence of AD remains to be resolved. To better understand the role of RELN pathway in the development of AD, we examined the expression profile of RELN and its downstream signaling members APOER2, VLDLR, and DAB1 in AD-vulnerable regions of transgenic and wildtype mice as well as in AD patients and controls across disease stages and/or aging. We show that both AD pathology and aging are associated with perturbation of the RELN pathway in a species-, region-, and molecule-specific manner. Further, we show that depletion of RELN, but not its downstream signaling molecules, is detectable long before the onset of amyloid-β pathology in the murine hippocampus and in a pre-clinical AD stage in the human frontal cortex. This early event hints at a possible causative role of RELN decline in the precipitation of AD pathology and supports RELN's potential as a pre-clinical marker for AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Reelin pathway was recognized to be involved in AD development since its impairment favors amyloidogenic Aβ processing and tau hyperphosphorylation [91,92].”
From The Emerging Role of PCSK9 in the Pathogenesis of Alzheimer’s Disease: A Possible Target for the Disease Treatment (2024) · cites this paper as [92]
In the citing paper
“Altered cleavage of Reelin was also found in AD mice as well as postmortem brain tissue and the cerebrospinal fluid of human AD subjects (89).”
From Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses (2017) · cites this paper as [89]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“AD severity was classified by two neuropathologists utilizing the CERAD [41] and Braak & Braak [42] staging.”
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · cited 1×
“Neuropathologically, AD is characterized by neurofibrillary tangles composed of hyperphosphorylated tau [18] and senile plaques [19], representing”
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 1×
“AD severity was classified by two neuropathologists utilizing the CERAD [41] and Braak & Braak [42] staging.”
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
A protein related to extracellular matrix proteins deleted in the mouse mutant reeler
D'Arcangelo, G., G. Miao, G., Chen, S.-C., Scares, H. D., Morgan, J. I., & Curran, T. (1995) · Nature · doi:10.1038/374719a0 · Cited by 1,748 · cited 1×
“During developmental stages, RELN is strongly expressed by Cajal-Retzius neurons [8], enabling proper neocortical lamination and cerebellar foliation [9–12].”
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., & Herz, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80782-5 · Cited by 1,261
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · cited 1×
“[40] were analyzed at different stages of the disease”
Hiesberger, T., Trommsdorff, M., Howell, B. W., Goffinet, A., Mumby, M. C., Cooper, J. A., & Herz, J. (1999) · Neuron · doi:10.1016/s0896-6273(00)80861-2 · Cited by 916 · cited 2×
“Reelin (RELN) is a highly conserved extracellular glycoprotein with signaling properties, predominantly mediated by the binding of processed RELN fragments to the membranous apolipoprotein E receptor 2 (APOER2, also known as LRP8) and the very low density lipoprotein receptor (VLDLR), which in turn induces the phospho…”
Haass, C., Koo, E. H., Mellon, A., Hung, A. Y., & Selkoe, D. J. (1992) · Nature · doi:10.1038/357500a0 · Cited by 899 · cited 1×
“precursor (A PP) [20].”
Reelin Is a Ligand for Lipoprotein Receptors
D'Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D. S., Sheldon, M., & Curran, T. (1999) · Neuron · doi:10.1016/s0896-6273(00)80860-0 · Cited by 808 · cited 1×
“[4, 5] essential for neuronal migration and positioning [6, 7].”
Cited by
Costa, L. G., Cole, T. B., Dao, K., Chang, Y.-C., Coburn, J., & Garrick, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107523 · Cited by 484
“, 2010; Mota, Ferreira, & Rego, 2014b; Yu, Tan, Yu, Xie, & Tan, 2016), and in brains of AD patients, particularly in the early stages (Chin et al., 2007; Herring et al., 2012).”
The involvement of Reelin in neurodevelopmental disorders
Folsom, T. D., & Fatemi, S. H. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.015 · Cited by 275
“…et al. 2003 No change in Reelin expression Increased expression of Reelin 180 kDa in frontal cortex but not cerebellum; altered glycosylation of Reelin Botella López et al. 2006 Reduced expression of Reelin in FC Herring et al. 2012 IR, immunoreactivity; PFC, prefrontal cortex Neuropharmacology.”
BackgroundResultDysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors
Mota, S. I., Ferreira, I. L., & Rego, A. C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.013 · Cited by 206
“Additionally to a decrease in mRNA levels, the decrease in GluN2B and GluN2A subunits could be due also to a decrease in reelin levels, a protein that mediates NMDAR activity, and which is depleted in AD brains (Herring et al., 2012).”
Jossin, Y. (2020) · Biomolecules · doi:10.3390/biom10060964 · Cited by 202
Ramanan, V. K., & Saykin, A. J. (2013) · Europe PMC (PubMed Central) · Cited by 251
Metadata
- Authors
- Herring, A., Donath, A., Steiner, K. M., Widera, M. P., Hamzehian, S., Kanakis, D., Kölble, K., ElAli, A., Hermann, D. M., Paulus, W., & Keyvani, K.
- Affiliations
- Essen University Hospital (DE)
- University Hospital Münster (DE)
- Corresponding author
- Keyvani, Kathy
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2012-06-18
- Volume
- 30
- Issue
- 4
- Pages
- 963-979
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1537020271
- Cited by
- 92
- References
- 51
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 4 · 2016: 13 · 2015: 5 · 2014: 9 · 2013: 9 · 2012: 3
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- reelin, Alzheimer's disease
- MeSH terms
- Reelin Protein, Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Female, Frontal Lobe, Humans, Male, Mice, Inbred C3H, Mice, Inbred C57BL, Mice, Transgenic, Nerve Tissue Proteins, Serine Endopeptidases, Biomarkers, Cell Adhesion Molecules, Neuronal, Extracellular Matrix Proteins, Early Diagnosis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reelin Depletion is an Early Phenomenon of Alzheimer's Pathology. https://app.cochat.ai/papers/10.3233/jad-2012-112069
- The paper
- Herring, A., Donath, A., Steiner, K. M., Widera, M. P., Hamzehian, S., Kanakis, D., Kölble, K., ElAli, A., Hermann, D. M., Paulus, W., & Keyvani, K. (2012). Reelin Depletion is an Early Phenomenon of Alzheimer's Pathology. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-2012-112069
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.